InsiderTrades.com logo

SABS Insider Trading

Insider Ownership Percentage: 25.06%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

SAB Biotherapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at SAB Biotherapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

SAB Biotherapeutics Share Price & Price History

Current Price: $3.96
Price Change: ▼ Price Decrease of -0.03 (-0.75%)
As of 12/17/2025 05:00 PM ET

This chart shows the closing price history over time for SABS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

SAB Biotherapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/7/2023Eddie Joe SullivanCEOBuy1,740$0.88$1,531.205,232,304View SEC Filing Icon  
11/30/2023Michael KingCFOBuy5,000$0.90$4,500.005,000View SEC Filing Icon  
11/29/2023Samuel J ReichChairmanBuy11,000$0.89$9,790.00219,001View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for SAB Biotherapeutics (NASDAQ:SABS)

7.82% of SAB Biotherapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at SABS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

SAB Biotherapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2025Woodline Partners LP2,850,881$5.73M0.0%N/A27.383%Search for SEC Filing on Google Icon
11/17/2025Vivo Capital LLC11,420,000$22.95M1.8%N/A109.692%Search for SEC Filing on Google Icon
11/17/2025RA Capital Management L.P.4,401,500$8.85M0.1%N/A42.277%Search for SEC Filing on Google Icon
11/17/2025Commodore Capital LP4,401,500$8.85M0.4%N/A42.277%Search for SEC Filing on Google Icon
11/14/2025Virtu Financial LLC19,982$40K0.0%N/A0.192%Search for SEC Filing on Google Icon
11/14/2025ADAR1 Capital Management LLC15,000$30K0.0%N/A0.144%Search for SEC Filing on Google Icon
11/12/2025Dimensional Fund Advisors LP15,781$32K0.0%N/A0.152%Search for SEC Filing on Google Icon
10/23/2025HB Wealth Management LLC307,500$0.62M0.0%N/A2.954%Search for SEC Filing on Google Icon
5/7/2025HB Wealth Management LLC263,200$0.36M0.0%+10.9%2.833%Search for SEC Filing on Google Icon
4/29/2025Silver Oak Securities Incorporated20,188$30K0.0%N/A0.217%Search for SEC Filing on Google Icon
4/21/2025Silver Oak Securities Incorporated20,188$30K0.0%N/A0.217%Search for SEC Filing on Google Icon
2/17/2025Millennium Management LLC29,411$0.11M0.0%-43.4%0.319%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp11,387$43K0.0%N/A0.123%Search for SEC Filing on Google Icon
2/14/2025Diadema Partners LP30,000$0.11M0.0%N/A0.325%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC80,234$0.31M0.0%+18.8%0.869%Search for SEC Filing on Google Icon
1/15/2025HB Wealth Management LLC237,400$0.98M0.0%+118.6%2.572%Search for SEC Filing on Google Icon
11/15/2024Kovitz Investment Group Partners LLC19,201$52K0.0%N/A0.208%Search for SEC Filing on Google Icon
11/15/2024RTW Investments LP635,276$1.72M0.0%-17.2%6.883%Search for SEC Filing on Google Icon
7/17/2024First PREMIER Bank19,386$60K0.0%N/A0.210%Search for SEC Filing on Google Icon
5/16/2024BVF Inc. IL917,826$4.17M0.1%-90.0%9.944%Search for SEC Filing on Google Icon
2/15/2024BVF Inc. IL9,178,282$6.31M0.2%N/A175.426%Search for SEC Filing on Google Icon
2/14/2024Commodore Capital LP1,831,746$1.26M0.1%N/A35.024%Search for SEC Filing on Google Icon
2/14/2024RTW Investments LP9,178,282$6.31M0.1%N/A175.493%Search for SEC Filing on Google Icon
11/8/2023Pathstone Family Office LLC506,513$0.32M0.0%N/A0.968%Search for SEC Filing on Google Icon
8/9/2023Institutional & Family Asset Management LLC192,027$0.16M0.0%+28.2%0.381%Search for SEC Filing on Google Icon
2/2/2023Silver Oak Securities Incorporated51,941$31K0.0%N/A0.121%Search for SEC Filing on Google Icon
11/7/2022Institutional & Family Asset Management LLC149,774$0.11M0.0%+91.7%0.348%Search for SEC Filing on Google Icon
10/20/2022First PREMIER Bank807,535$0.57M0.2%+23.8%1.877%Search for SEC Filing on Google Icon
8/15/2022LGL Partners LLC23,000$33K0.0%N/A0.054%Search for SEC Filing on Google Icon
8/3/2022AE Wealth Management LLC18,700$27K0.0%N/A0.044%Search for SEC Filing on Google Icon
7/26/2022First PREMIER Bank652,440$0.95M0.3%N/A1.519%Search for SEC Filing on Google Icon
5/9/2022Qube Research & Technologies Ltd24,179$91K0.0%+43.8%0.056%Search for SEC Filing on Google Icon
2/14/2022Radcliffe Capital Management L.P.546,658$5.52M0.1%N/A1.257%Search for SEC Filing on Google Icon
2/14/2022ETF Managers Group LLC13,202$0.11M0.0%N/A0.030%Search for SEC Filing on Google Icon
2/14/2022Institutional & Family Asset Management LLC78,115$0.61M0.1%N/A0.180%Search for SEC Filing on Google Icon
2/10/2022Qube Research & Technologies Ltd16,817$0.13M0.0%N/A0.039%Search for SEC Filing on Google Icon
2/9/2022Wolverine Asset Management LLC6,602$51K0.0%N/A0.015%Search for SEC Filing on Google Icon
2/9/2022Alps Advisors Inc.50,306$0.39M0.0%N/A0.116%Search for SEC Filing on Google Icon
2/3/2022Spectrum Management Group LLC5,030$39K0.0%N/A0.012%Search for SEC Filing on Google Icon
2/1/2022Qube Research & Technologies Ltd16,817$0.13M0.0%N/A0.039%Search for SEC Filing on Google Icon
1/19/2022First PREMIER Bank832,555$6.50M1.7%N/A1.915%Search for SEC Filing on Google Icon
1/18/2022Nadler Financial Group Inc.11,000$86K0.0%N/A0.025%Search for SEC Filing on Google Icon
11/17/2021Tudor Investment Corp Et Al60,000$0.61M0.0%N/A0.406%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
SAB Biotherapeutics logo
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at infectious diseases and immune and autoimmune disorders, including infectious diseases, influenza, CDI, type 1 diabetes, organ transplantation, and oncology, as well as immunology, gastroenterology, and respiratory diseases. The company also uses its DiversitAb immunotherapy platform to produce fully-human polyclonal antibodies without the need for human donors or plasma. In addition, its lead product candidate SAB-142, a human, multi-target anti-thymocyte globulin treatment, currently under Phase 1 trials in delaying the onset or progression of type 1 diabetes. Further, the company develops SAB-176, a multivalent, broadly neutralizing - human polyclonal immunoglobulin therapeutic candidate, currently in Phase 2a development for the treatment or prevention of severe influenza. SAB Biotherapeutics, Inc. was founded in 2014 and is headquartered in Miami Beach, Florida.
Read More on SAB Biotherapeutics

Today's Range

Now: $3.96
Low: $3.91
High: $4.03

50 Day Range

MA: $3.34
Low: $2.17
High: $4.04

52 Week Range

Now: $3.96
Low: $1.00
High: $6.60

Volume

631,878 shs

Average Volume

272,055 shs

Market Capitalization

$188.54 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.58

Who are the major institutional investors of SAB Biotherapeutics?

SAB Biotherapeutics' top institutional shareholders include:
  1. Vivo Capital LLC — 109.69%
  2. RA Capital Management L.P. — 42.28%
  3. Commodore Capital LP — 42.28%
  4. Woodline Partners LP — 27.38%
  5. HB Wealth Management LLC — 2.95%
  6. Virtu Financial LLC — 0.19%
Learn More about top institutional investors of SAB Biotherapeutics stock.

Which major investors are buying SAB Biotherapeutics stock?

Within the previous quarter, SABS stock was acquired by institutional investors including:
  1. Vivo Capital LLC
  2. RA Capital Management L.P.
  3. Commodore Capital LP
  4. Woodline Partners LP
  5. HB Wealth Management LLC
  6. Virtu Financial LLC
  7. Dimensional Fund Advisors LP
  8. ADAR1 Capital Management LLC